Daré Bioscience, Inc.
DARE
$0.72
$0.011.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.98M | -3.00M | -1.44M | -3.56M | -4.02M |
| Total Depreciation and Amortization | 572.10K | 554.60K | 534.40K | 481.90K | 454.20K |
| Total Amortization of Deferred Charges | -- | -- | -135.90K | 124.30K | -- |
| Total Other Non-Cash Items | 698.80K | 595.50K | 384.80K | 596.10K | 620.70K |
| Change in Net Operating Assets | -5.06M | -3.67M | 2.10M | 1.92M | -2.48M |
| Cash from Operations | -6.78M | -5.52M | 1.44M | -442.10K | -5.42M |
| Capital Expenditure | -80.60K | -- | -206.60K | -174.70K | 153.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -80.60K | -- | -206.60K | -174.70K | 153.40K |
| Total Debt Issued | -- | -- | 0.00 | 486.70K | -- |
| Total Debt Repaid | -448.20K | -1.08M | -529.00K | -580.50K | -521.30K |
| Issuance of Common Stock | 166.70K | 94.90K | 1.27M | 18.74M | 475.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 1.23M | 297.20K | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -28.50K | -321.70K | -- | 2.50K |
| Cash from Financing | 951.20K | -715.50K | 424.10K | 18.65M | -43.80K |
| Foreign Exchange rate Adjustments | 2.20K | 44.50K | -25.70K | 6.90K | 12.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.90M | -6.19M | 1.64M | 18.04M | -5.30M |